Adrian Hobson

Person

Worcester, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Fused heterocyclic derivatives as S1P modulators
- Patent number RE48301
- Issue date Nov 10, 2020
- AbbVie B.V.
- Pieter Smid
Information Patent Grant
Spiro-cyclic amine derivatives as S1P modulators
- Patent number 10,807,991
- Issue date Oct 20, 2020
- AbbVie B.V.
- Axel Stoit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glucocorticoid receptor agonist and immunoconjugates thereof
- Patent number 10,772,970
- Issue date Sep 15, 2020
- AbbVie Inc.
- Adrian Hobson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glucocorticoid receptor agonist and immunoconjugates thereof
- Patent number 10,668,167
- Issue date Jun 2, 2020
- AbbVie Inc.
- Michael J. McPherson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiro-cyclic amine derivatives as S1P modulators
- Patent number 10,179,791
- Issue date Jan 15, 2019
- AbbVie B.V.
- Axel Stoit
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nuclear receptor modulators
- Patent number 10,106,501
- Issue date Oct 23, 2018
- AbbVie Inc.
- Maria A. Argiriadi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiro-cyclic amine derivatives as S1P modulators
- Patent number 9,951,084
- Issue date Apr 24, 2018
- Abb Vie B.V.
- Axel Stoit
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic derivatives as S1P modulators
- Patent number 9,670,220
- Issue date Jun 6, 2017
- AbbVie B.V.
- Pieter Smid
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(Thio)morpholine derivatives as S1P modulators
- Patent number 9,273,017
- Issue date Mar 1, 2016
- ABBVIE BAHAMAS LIMITED
- Wouter I. Iwema Bakker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
5-substituted indazoles as kinase inhibitors
- Patent number 9,163,007
- Issue date Oct 20, 2015
- AbbVie Inc.
- Irini Akritopoulou-Zanze
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 2,10-dihydro-9-oxa-1,2,4A-triazaphenanthren-3-ones and...
- Patent number 9,115,151
- Issue date Aug 25, 2015
- AbbVie Inc.
- Dawn M. George
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic derivatives as S1P modulators
- Patent number 9,096,612
- Issue date Aug 4, 2015
- AbbVie B.V.
- Pieter Smid
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(Thio)morpholine derivatives as S1P modulators
- Patent number 9,045,441
- Issue date Jun 2, 2015
- AbbVie Bahamas Limited
- Wouter I. Iwema Bakker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-(4-pyridinyl)-benzamides and their use as rock activity modulators
- Patent number 8,895,749
- Issue date Nov 25, 2014
- AbbVie Inc.
- Helmut Mack
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic derivatives as S1P modulators
- Patent number 8,796,262
- Issue date Aug 5, 2014
- AbbVie B.V.
- Pieter Smid
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aminopyrrolidines as chemokine receptor antagonists
- Patent number 8,754,107
- Issue date Jun 17, 2014
- AbbVie Inc.
- Dawn M. George
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
5-substituted indazoles as kinase inhibitors
- Patent number 8,648,069
- Issue date Feb 11, 2014
- AbbVie Inc.
- Irini Akritopoulou-Zanze
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-(4-pyridinyl)-benzamides and their use as rock activity modulators
- Patent number 8,445,686
- Issue date May 21, 2013
- AbbVie Inc.
- Helmut Mack
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sphingosine-1-phosphate receptor agonist and antagonist compounds
- Patent number 8,217,027
- Issue date Jul 10, 2012
- Abbott Laboratories
- Grier A. Wallace
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxadiazole compounds
- Patent number 7,834,039
- Issue date Nov 16, 2010
- Abbott Laboratories
- Adrian D. Hobson
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTI-CD19 ANTIBODY DRUG CONJUGATES
- Publication number 20240100181
- Publication date Mar 28, 2024
- AbbVie Biotherapeutics Inc.
- Chewei A. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEAR RECEPTOR MODULATORS
- Publication number 20230066771
- Publication date Mar 2, 2023
- ABBVIE INC.
- Maria A. Argiriadi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
- Publication number 20220354959
- Publication date Nov 10, 2022
- ABBVIE INC.
- Michael J. MCPHERSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD40 ANTIBODY DRUG CONJUGATES
- Publication number 20220265842
- Publication date Aug 25, 2022
- ABBVIE INC.
- Adrian D. Hobson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NUCLEAR RECEPTOR MODULATORS
- Publication number 20210130293
- Publication date May 6, 2021
- ABBVIE INC.
- Maria A. Argiriadi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIRO-CYCLIC AMINE DERIVATIVES AS S1P MODULATORS
- Publication number 20210130364
- Publication date May 6, 2021
- AbbVie B.V.
- Axel Stoit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
- Publication number 20210015938
- Publication date Jan 21, 2021
- ABBVIE INC.
- Adrian D. Hobson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
- Publication number 20200338208
- Publication date Oct 29, 2020
- ABBVIE INC.
- Michael J. MCPHERSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
- Publication number 20190262465
- Publication date Aug 29, 2019
- ABBVIE INC.
- Michael J. MCPHERSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPIRO-CYCLIC AMINE DERIVATIVES AS S1P MODULATORS
- Publication number 20190218227
- Publication date Jul 18, 2019
- AbbVie B.V.
- Axel Stoit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
- Publication number 20190167804
- Publication date Jun 6, 2019
- ABBVIE INC.
- Adrian Hobson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEAR RECEPTOR MODULATORS
- Publication number 20190055196
- Publication date Feb 21, 2019
- ABBVIE INC.
- Maria A. Argiriadi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
- Publication number 20180126000
- Publication date May 10, 2018
- ABBVIE INC.
- Michael J. MCPHERSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEAR RECEPTOR MODULATORS
- Publication number 20160362370
- Publication date Dec 15, 2016
- ABBVIE INC.
- Maria A. Argiriadi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIRO-CYCLIC AMINE DERIVATIVES AS S1P MODULATORS
- Publication number 20160340363
- Publication date Nov 24, 2016
- AbbVie B.V.
- Axel Stoit
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC DERIVATIVES AS S1P MODULATORS
- Publication number 20150284403
- Publication date Oct 8, 2015
- AbbVie B.V.
- Pieter Smid
- C07 - ORGANIC CHEMISTRY
Information Patent Application
(THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS
- Publication number 20150239857
- Publication date Aug 27, 2015
- ABBVIE BAHAMAS LIMITED
- Wouter I. Iwema Bakker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-(4-PYRIDINYL)-BENZAMIDES AND THEIR USE AS ROCK ACTIVITY MODULATORS
- Publication number 20150105386
- Publication date Apr 16, 2015
- AbbVie Deutschland GmbH & Co KG
- Helmut Mack
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5-SUBSTITUTED INDAZOLES AS KINASE INHIBITORS
- Publication number 20140343066
- Publication date Nov 20, 2014
- Irini Akritopoulou-Zanze
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZINONE COMPOUNDS
- Publication number 20140206663
- Publication date Jul 24, 2014
- Jianfei Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC DERIVATIVES AS S1P MODULATORS
- Publication number 20140066433
- Publication date Mar 6, 2014
- Pieter Smid
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-(4-PYRIDINYL)-BENZAMIDES AND THEIR USE AS ROCK ACTIVITY MODULATORS
- Publication number 20130310378
- Publication date Nov 21, 2013
- ABBVIE INC.
- Helmut Mack
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL TRICYCLIC COMPOUNDS
- Publication number 20130072470
- Publication date Mar 21, 2013
- ABBVIE INC.
- Neil Wishart
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Nuclear Hormone Receptor Modulators
- Publication number 20120238549
- Publication date Sep 20, 2012
- Abbott Laboratories
- Kevin P. Cusack
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Oxadiazole Compounds
- Publication number 20110207704
- Publication date Aug 25, 2011
- Abbott Laboratories
- Kevin P. Cusack
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL THIENOPYRROLE COMPOUNDS
- Publication number 20110152243
- Publication date Jun 23, 2011
- Abbott Laboratories
- Neil Wishart
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Agonists and Antagonists of the S1P5 Receptor, and Methods of Use T...
- Publication number 20100216762
- Publication date Aug 26, 2010
- Abbott Laboratories
- Christopher M. Harris
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF PROTEIN KINASES
- Publication number 20100035919
- Publication date Feb 11, 2010
- Abbott Laboratories
- Anil Vasudevan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
5-SUBSTITUTED INDAZOLES AS KINASE INHIBITORS
- Publication number 20090203690
- Publication date Aug 13, 2009
- Abbott Laboratories
- Irini Akritopoulou-Zanze
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel therapeutic compounds
- Publication number 20090069288
- Publication date Mar 12, 2009
- Eric C. Breinlinger
- C07 - ORGANIC CHEMISTRY

Adrian Hobson

Person

Patents Grantslast 30 patents

Fused heterocyclic derivatives as S1P modulators

Spiro-cyclic amine derivatives as S1P modulators

Glucocorticoid receptor agonist and immunoconjugates thereof

Glucocorticoid receptor agonist and immunoconjugates thereof

Spiro-cyclic amine derivatives as S1P modulators

Nuclear receptor modulators

Spiro-cyclic amine derivatives as S1P modulators

Fused heterocyclic derivatives as S1P modulators

(Thio)morpholine derivatives as S1P modulators

5-substituted indazoles as kinase inhibitors

Substituted 2,10-dihydro-9-oxa-1,2,4A-triazaphenanthren-3-ones and...

Fused heterocyclic derivatives as S1P modulators

(Thio)morpholine derivatives as S1P modulators

4-(4-pyridinyl)-benzamides and their use as rock activity modulators

Fused heterocyclic derivatives as S1P modulators

Aminopyrrolidines as chemokine receptor antagonists

5-substituted indazoles as kinase inhibitors

4-(4-pyridinyl)-benzamides and their use as rock activity modulators

Sphingosine-1-phosphate receptor agonist and antagonist compounds

Oxadiazole compounds

Patents Applicationslast 30 patents

ANTI-CD19 ANTIBODY DRUG CONJUGATES

NUCLEAR RECEPTOR MODULATORS

GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF

ANTI-CD40 ANTIBODY DRUG CONJUGATES

NUCLEAR RECEPTOR MODULATORS

SPIRO-CYCLIC AMINE DERIVATIVES AS S1P MODULATORS

GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF

GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF

GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF

SPIRO-CYCLIC AMINE DERIVATIVES AS S1P MODULATORS

GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF

NUCLEAR RECEPTOR MODULATORS

GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF

NUCLEAR RECEPTOR MODULATORS

SPIRO-CYCLIC AMINE DERIVATIVES AS S1P MODULATORS

FUSED HETEROCYCLIC DERIVATIVES AS S1P MODULATORS

(THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS

4-(4-PYRIDINYL)-BENZAMIDES AND THEIR USE AS ROCK ACTIVITY MODULATORS

5-SUBSTITUTED INDAZOLES AS KINASE INHIBITORS

TRIAZINONE COMPOUNDS

FUSED HETEROCYCLIC DERIVATIVES AS S1P MODULATORS

4-(4-PYRIDINYL)-BENZAMIDES AND THEIR USE AS ROCK ACTIVITY MODULATORS

NOVEL TRICYCLIC COMPOUNDS

Nuclear Hormone Receptor Modulators

Novel Oxadiazole Compounds

NOVEL THIENOPYRROLE COMPOUNDS

Agonists and Antagonists of the S1P5 Receptor, and Methods of Use T...

COMPOUNDS USEFUL AS INHIBITORS OF PROTEIN KINASES

5-SUBSTITUTED INDAZOLES AS KINASE INHIBITORS

Novel therapeutic compounds